SB1906 104TH GENERAL ASSEMBLY

LRB104 09739 BDA 19805 b

104TH GENERAL ASSEMBLY
State of Illinois
2025 and 2026
SB1906

Introduced 2/6/2025, by Sen. Mike Simmons

SYNOPSIS AS INTRODUCED:

New Act

Creates the Prescription Drug Purchasing Task Force Act. Creates a Prescription Drug Purchasing Task Force in the Department of Healthcare and Family Services to study the different ways that other states are using multi-state prescription drug purchasing pools to increase the State's negotiating power and lower prices for patients. Provides for duties of the Task Force. Provides that the Department of Healthcare and Family Services shall provide administrative and other support to the Task Force. Provides that, on or before July 31, 2026, the Task Force shall report its findings and recommendations to the General Assembly and to the Governor. Provides that the Prescription Drug Purchasing Task Force is abolished and the Act is repealed on January 1, 2027.

A BILL FOR

AN ACT concerning State government.

Be it enacted by the People of the State of Illinois, represented in the General Assembly:

Section 1. Short title. This Act may be cited as the Prescription Drug Purchasing Task Force Act.

Section 5. The Prescription Drug Purchasing Task Force. There is hereby created a Prescription Drug Purchasing Task Force in the Department of Healthcare and Family Services to study the different ways that other states are using multistate prescription drug purchasing pools to increase the State's negotiating power and lower prices for patients. The Task Force shall consist of the following members:

(1) four members shall be appointed by the Governor as follows:

(A) one physician licensed to practice medicine in all its branches;

(B) one pharmacist;

(C) one clinical representative from a statewide organization representing hospitals; and

(D) one member from the general public;

(2) one member shall be appointed by the Senate President;

(3) one member shall be appointed by the Speaker of the Illinois House of Representatives;

(4) one member shall be appointed by the Minority Leader of the Illinois Senate;

(5) one member shall be appointed by the Minority Leader of the Illinois House of Representatives;

(6) one member shall be the Director of Public Health, or his or her designee;

(7) one member shall be the Director of Central Management Services, or his or her designee;

(8) one member shall be the Director of Healthcare and Family Services, or his or her designee; and

(9) one member shall be the Director of Insurance, or his or her designee.

Members shall serve 2-year terms. Members shall be appointed within 30 days after the effective date of this Act.

The Task Force may appoint a chairperson by majority vote and other officers as it deems appropriate.

The members of the Task Force shall receive no compensation for their services as members of the Task Force.

No member of the Task Force shall have any financial association or fiduciary interest in any pharmaceutical company.

Section 10. Duties. The Task Force shall:

(1) identify a plan to enable the State to bulk purchase prescription drugs, including, but not limited to, identifying what other states are doing to purchase prescription drugs in bulk;

(2) recommend ways the State can negotiate with wholesalers and manufacturers in order to cut drug prices, including, but not limited to, Medicaid prices;

(3) identify and make recommendations for the State to join an existing interstate bulk purchasing pool in order to cut prices for prescription drugs; and

(4) identify high cost prescription drugs that are also in high demand in the State, and identify price ranges for those drugs in Illinois compared to other states.

Section 15. Administrative support. The Department of Healthcare and Family Services shall provide administrative and other support to the Task Force.

Section 20. Report. On or before July 31, 2026, the Task Force shall report its findings and recommendations to the General Assembly, by filing copies of its report as provided in Section 3.1 of the General Assembly Organization Act, and to the Governor.

Section 25. Task Force abolished. The Prescription Drug Purchasing Task Force is abolished and this Act is repealed on January 1, 2027.